Is TB-500 Legal in Georgia? How to Access It Legally

HealthRX.com

Federal rules do not settle TB-500 legality in Georgia

Print or save as PDF

See the public record for TB-500

  • FDA approval / None; no approved drug contains TB-500 in any market FDA checked [1]
  • FDA pharmacy lists / In none of the three interim categories; not on the bulks list [2][9]
  • Outsourcing facility list / Not on it [3]
  • Safety-risk page / In the nominated-but-withdrawn table, not the active category 2 table [6]
  • HHS draft policy, October 2026 / Covers TB-500 acetate for injection; not binding, not an approval [4][5]
  • WADA / Prohibited at all times under S2.3 [7]
  • Georgia / The federal documents do not set state law

Is TB-500 legal in Georgia?

The FDA and HHS documents describe federal approval status, compounding-list status, and a draft enforcement policy. They do not decide what Georgia law permits [1][2][3][4][5]. Any Georgia-specific answer would have to come from Georgia's own rules, which this page does not cover.

Under federal compounding rules, a state-licensed pharmacy generally may use only a bulk substance that complies with a USP or National Formulary monograph, is a component of an FDA-approved drug, or appears on FDA's bulks list [8]. TB-500 meets none of the three: FDA found no USP or NF monograph for it and no approved drug containing it, and it is not on the pharmacy bulks list [1][2][9].

Questions worth asking

Choose the questions you want to keep

Where TB-500 sits on FDA's lists

TB-500 is a synthetic 7-amino-acid fragment of the 43-amino-acid protein thymosin beta-4 (residues 17 to 23, N-acetylated), not the full-length protein, and it is sold online as a research-use-only powder [1]. FDA found no pharmacy marketing a compounded TB-500 product [1].

It appears in the nominated-but-withdrawn table on FDA's safety-risk page, not the active category 2 table; removal from category 2 was not a finding that it is safe [6]. In July 2026 FDA staff proposed against adding either the free base or the acetate to the pharmacy bulks list, citing no human data of any kind, no impurity or aggregate data, immunogenicity risk and existing approved wound treatments [1]. FDA's Pharmacy Compounding Advisory Committee voted in favour of adding it on July 23, 2026, against that recommendation; the vote is advice, and placing a substance on the list takes formal rulemaking [9][4].

What the draft federal policy would cover

HHS filed a draft enforcement-discretion policy on October 28, 2026 (Federal Register document 2026-22192, comments due two weeks after the scheduled October 30 publication) naming six peptides, TB-500 among them [4][5]. For TB-500 it covers the acetate form injected subcutaneously or intramuscularly where a single active ingredient, a patient-specific prescription, bulk substance from an FDA-registered manufacturer with a certificate of analysis, and a 'compounded drug product' label are in place [4][5].

The notice says it does not establish rights for any person, is not binding on HHS or the public, and may be revisited, for example after a safety signal [4]. It does not put TB-500 on any list [4]. There is no approved dose and no human dosing study; the nomination FDA reviewed proposed a 3 mg/mL lyophilized powder for injection, a proposed formulation rather than a recommended dose [1].

Safety and testing

FDA's adverse-event search through March 26, 2025 retrieved no TB-500 reports, and its food and supplement complaint system retrieved two cases about a blended TB-500 and BPC-157 product with no safety assessment; FDA found no published case reports, so human safety is unknown [1]. Its stated concern for injectable TB-500 is immunogenicity, and it found no immunogenicity, aggregation or nonclinical toxicity studies [1].

WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3, prohibited at all times, in and out of competition, on both the 2026 and 2027 lists [7][10].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. Why do the FDA and HHS documents not settle whether TB-500 is legal to access in Georgia?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Is TB-500 covered by Georgia law?
The federal documents do not say. They set out the federal position: TB-500 is not FDA-approved and is not on FDA's compounding lists [1][2][3].
Can a Georgia pharmacy compound TB-500 on a prescription?
Not through the ordinary federal pathway: no monograph applies, it is not a component of an approved drug, and it is not on the bulks list [1][2][9]. The draft HHS policy would cover TB-500 acetate for injection where its conditions are met, but it is not final [4][5].
Do I need a prescription for TB-500?
There is no FDA-approved TB-500 product. The draft HHS policy lists a patient-specific prescription among its conditions for compounded TB-500 acetate [1][4][5].
Was TB-500 made legal in 2026?
No. The July 23, 2026 committee vote was advice only, and the HHS policy filed October 28, 2026 is a draft that establishes no rights [9][4].
Show all 10 referencesHide references
Evidence overview for Is TB-500 Legal in Georgia? How to Access It Legally